1
|
Ndlovu MT, Harding CR, Kaschula CH, Chellan P. Synthesis of ferrocenyl benzimidazole derivatives as novel anti- Toxoplasma gondii agents. NEW J CHEM 2024; 48:16415-16428. [PMID: 39268224 PMCID: PMC11385693 DOI: 10.1039/d3nj05116a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Accepted: 08/31/2024] [Indexed: 09/15/2024]
Abstract
Toxoplasmosis, a disease caused by the apicomplexan parasite Toxoplasma gondii, affects up to one third of the global population. Although immunocompetent individuals rarely experience severe symptoms, those with immunodeficiencies may potentially face fatal disease. The frontline treatments are currently sulphadiazine and pyrimethamine, which suffer from adverse side effects, and lack efficiency in clearing parasite cysts from the muscles and brain of patients. To address the need for novel, more effective, and less toxic treatments, four new ferrocenyl benzimidazole complexes 15-18 were synthesised and evaluated against the ΔKu80:mNeonGreen strain of T. gondii. Complexes 15 and 17 were found to be active with EC50 values of 17.9 and 17.5 μM respectively, with comparable activity to pyrimethamine, which had an EC50 value of 13.8 μM, and less effective than sulphadiazine, which had an EC50 value of 2.56 μM. Additionally, the compounds were found to be relatively non-toxic against HEK 293T and PNT1A human cell lines. Further investigations found that the complexes act by generating reactive oxygen species (ROS) through the ferrocenyl moiety. These complexes show potential for the development of new treatments against Toxoplasmosis.
Collapse
Affiliation(s)
- Malcolm T Ndlovu
- Department of Chemistry and Polymer Science, Stellenbosch University Stellenbosch Western Cape South Africa +2721 8083327
| | - Clare R Harding
- Wellcome Centre for Integrative Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow Glasgow UK
| | - Catherine H Kaschula
- Department of Chemistry and Polymer Science, Stellenbosch University Stellenbosch Western Cape South Africa +2721 8083327
| | - Prinessa Chellan
- Department of Chemistry and Polymer Science, Stellenbosch University Stellenbosch Western Cape South Africa +2721 8083327
| |
Collapse
|
2
|
Rehl KM, Selvakumar J, Pitsch RL, Hoang D, Arumugam K, Harshman SW, Gorfe AA, Cho KJ. A new ferrocene derivative blocks K-Ras localization and function by oxidative modification at His95. Life Sci Alliance 2023; 6:e202302094. [PMID: 37666666 PMCID: PMC10477449 DOI: 10.26508/lsa.202302094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2023] [Revised: 08/23/2023] [Accepted: 08/24/2023] [Indexed: 09/06/2023] Open
Abstract
Ras proteins are membrane-bound GTPases that regulate essential cellular processes at the plasma membrane (PM). Constitutively active mutations of K-Ras, one of the three Ras isoforms in mammalian cells, are frequently found in human cancers. Ferrocene derivatives, which elevate cellular reactive oxygen species (ROS), have shown to block the growth of non-small cell lung cancers harboring oncogenic mutant K-Ras. Here, we tested a novel ferrocene derivative on the growth of pancreatic ductal adenocarcinoma and non-small cell lung cancer. Our compound, which elevated cellular ROS levels, inhibited the growth of K-Ras-driven cancers, and abrogated the PM binding and signaling of K-Ras in an isoform-specific manner. These effects were reversed upon antioxidant supplementation, suggesting a ROS-mediated mechanism. We further identified that K-Ras His95 residue plays an important role in this process, and it is putatively oxidized by cellular ROS. Together, our study demonstrates that the redox system directly regulates K-Ras/PM binding and signaling via oxidative modification at the His95, and proposes a role of oncogenic mutant K-Ras in the recently described antioxidant-induced growth and metastasis of K-Ras-driven cancers.
Collapse
Affiliation(s)
- Kristen M Rehl
- Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA
| | - Jayaraman Selvakumar
- Department of Chemistry, College of Science and Mathematics, Wright State University, Dayton, OH, USA
| | - Rhonda L Pitsch
- https://ror.org/02e2egq70 Air Force Research Laboratory, Wright-Patterson AFB, OH, USA
| | - Don Hoang
- Department of Chemistry, College of Science and Mathematics, Wright State University, Dayton, OH, USA
| | - Kuppuswamy Arumugam
- Department of Chemistry, College of Science and Mathematics, Wright State University, Dayton, OH, USA
| | - Sean W Harshman
- https://ror.org/02e2egq70 Air Force Research Laboratory, Wright-Patterson AFB, OH, USA
| | - Alemayehu A Gorfe
- Department of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA
| | - Kwang-Jin Cho
- Department of Biochemistry and Molecular Biology, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA
| |
Collapse
|
3
|
Allison M, Caramés-Méndez P, Hofmann BJ, Pask CM, Phillips RM, Lord RM, McGowan PC. Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl β-Diketonate Ligands. Organometallics 2023; 42:1869-1881. [PMID: 37592952 PMCID: PMC10428205 DOI: 10.1021/acs.organomet.2c00553] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Indexed: 08/19/2023]
Abstract
The synthesis and characterization of 24 ruthenium(II) arene complexes of the type [(p-cym)RuCl(Fc-acac)] (where p-cym = p-cymene and Fc-acac = functionalized ferrocenyl β-diketonate ligands) are reported, including single-crystal X-ray diffraction for 21 new complexes. Chemosensitivity studies have been conducted against human pancreatic carcinoma (MIA PaCa-2), human colorectal adenocarcinoma p53-wildtype (HCT116 p53+/+) and normal human retinal epithelial cell lines (APRE-19). The most active complex, which contains a 2-furan-substituted ligand (4), is 5x more cytotoxic than the analogs 3-furan complex (5) against MIA PaCa-2. Several complexes were screened under hypoxic conditions and at shorter-time incubations, and their ability to damage DNA was determined by the comet assay. Compounds were also screened for their potential to inhibit the growth of both bacterial and fungal strains.
Collapse
Affiliation(s)
- Matthew Allison
- School
of Chemistry, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K.
| | - Pablo Caramés-Méndez
- School
of Chemistry, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K.
- Department
of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, U.K.
| | - Benjamin J. Hofmann
- School
of Chemistry, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, U.K.
| | - Christopher M. Pask
- School
of Chemistry, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K.
| | - Roger M. Phillips
- Department
of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, U.K.
| | - Rianne M. Lord
- School
of Chemistry, University of East Anglia, Norwich Research Park, Norwich NR4 7TJ, U.K.
- School
of Chemistry and Biosciences, University
of Bradford, Bradford BD7 1DP, U.K.
| | - Patrick C. McGowan
- School
of Chemistry, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K.
| |
Collapse
|
4
|
Zamisa SJ, Adeleke AA, Devnarain N, Rhman MA, Owira PMO, Omondi B. The link between relative stability constant of DNA- and BSA-chromenopyrimidine complexes and cytotoxicity towards human breast cancer cells (MCF-7). RSC Adv 2023; 13:21820-21837. [PMID: 37475760 PMCID: PMC10354499 DOI: 10.1039/d3ra01741a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Accepted: 07/11/2023] [Indexed: 07/22/2023] Open
Abstract
In this study, we synthesized and characterized ten chromenopyrimidine derivatives using analytical and spectroscopic methods. Studies on DNA and albumin binding affinity, as well as cytotoxicity tests on human breast cancer (MCF-7) cells, of the chromenopyrimidines, were conducted. The natural logarithm of the relative stability constant of DNA- and BSA-chromenopyrimidine complexes [ln(KDNA/KBSA)] was used as a criterion for selecting compounds for cytotoxicity studies. We found that ln(KDNA/KBSA) was inversely related to IC50 values of the compounds in MCF-7 cells. The antiproliferative effects of the compounds were found to induce apoptosis in MCF-7 cells, which is a desired mechanism of cell death. Correlations between the DNA and albumin binding affinities of chromenopyrimidines were established. We propose that this relationship approach can, for a given set of compounds, assist in predicting the cytotoxicity of potential drug candidates towards MCF-7 cells based on their experimentally determined CT-DNA and BSA binding affinities.
Collapse
Affiliation(s)
- Sizwe J Zamisa
- School of Chemistry and Physics, University of KwaZulu-Natal Private Bag X54001 Durban 4000 South Africa
| | - Adesola A Adeleke
- School of Chemistry and Physics, University of KwaZulu-Natal Private Bag X54001 Durban 4000 South Africa
| | - Nikita Devnarain
- Molecular and Clinical Pharmacology Research Laboratory, Department of Pharmacology, Discipline of Pharmaceutical Science, University of KwaZulu-Natal Private Bag X54001 Durban 4000 South Africa
| | - Mahasin Abdel Rhman
- Molecular and Clinical Pharmacology Research Laboratory, Department of Pharmacology, Discipline of Pharmaceutical Science, University of KwaZulu-Natal Private Bag X54001 Durban 4000 South Africa
| | - Peter M O Owira
- Molecular and Clinical Pharmacology Research Laboratory, Department of Pharmacology, Discipline of Pharmaceutical Science, University of KwaZulu-Natal Private Bag X54001 Durban 4000 South Africa
| | - Bernard Omondi
- School of Chemistry and Physics, University of KwaZulu-Natal Private Bag X54001 Durban 4000 South Africa
| |
Collapse
|
5
|
Rehl KM, Selvakumar J, Hoang D, Arumugam K, Gorfe AA, Cho KJ. A new ferrocene derivative blocks KRAS localization and function by oxidative modification at His95. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.03.28.534499. [PMID: 37034642 PMCID: PMC10081197 DOI: 10.1101/2023.03.28.534499] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/19/2023]
Abstract
Ras proteins are membrane-bound GTPases that regulate essential cellular processes at the plasma membrane (PM). Constitutively active mutations of K-Ras, one of the three Ras isoforms in mammalian cells, are frequently found in human cancers. Ferrocene derivatives, which elevate cellular reactive oxygen species (ROS), have shown to block the growth of non-small cell lung cancers (NSCLCs) harboring oncogenic mutant K-Ras. Here, we developed and tested a novel ferrocene derivative on the growth of human pancreatic ductal adenocarcinoma (PDAC) and NSCLC. Our compound inhibited the growth of K-Ras-dependent PDAC and NSCLC and abrogated the PM binding and signaling of K-Ras, but not other Ras isoforms. These effects were reversed upon antioxidant supplementation, suggesting a ROS-mediated mechanism. We further identified K-Ras His95 residue in the G-domain as being involved in the ferrocene-induced K-Ras PM dissociation via oxidative modification. Together, our studies demonstrate that the redox system directly regulates K-Ras PM binding and signaling via oxidative modification at the His95, and proposes a role of oncogenic mutant K-Ras in the recently described antioxidant-induced metastasis in K-Ras-driven lung cancers.
Collapse
|
6
|
Gupta A, Das R, Chamoli A, Choithramani A, Kumar H, Patel S, Khude D, Bothra G, Wangdale K, Ghosh Chowdhury M, Rathod R, Mandoli A, Shard A. A Series of Ferrocene-Containing Pyrazolo[1,5- a]pyrimidines Induce a Strong Antiproliferative Effect against Oral Cancer Cells. Organometallics 2022. [DOI: 10.1021/acs.organomet.2c00348] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Astha Gupta
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Rudradip Das
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Ambika Chamoli
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Asmita Choithramani
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Hansal Kumar
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Sagarkumar Patel
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Datta Khude
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Gourav Bothra
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Khushal Wangdale
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Moumita Ghosh Chowdhury
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Rajeshwari Rathod
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Amit Mandoli
- Department of Biotechnology, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| | - Amit Shard
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research−Ahmedabad, Opposite Airforce Station, Palaj, Gandhinagar, Gujarat 382355, India
| |
Collapse
|
7
|
Schröder M, Petrova M, Vlahova Z, Dobrikov GM, Slavchev I, Pasheva E, Ugrinova I. In Vitro Anticancer Activity of Two Ferrocene-Containing Camphor Sulfonamides as Promising Agents against Lung Cancer Cells. Biomedicines 2022; 10:biomedicines10061353. [PMID: 35740374 PMCID: PMC9219647 DOI: 10.3390/biomedicines10061353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2022] [Revised: 05/31/2022] [Accepted: 06/06/2022] [Indexed: 11/16/2022] Open
Abstract
The successful design of antitumour drugs often combines in one molecule different biologically active subunits that can affect various regulatory pathways in the cell and thus achieve higher efficacy. Two ferrocene derivatives, DK-164 and CC-78, with different residues were tested for cytotoxic potential on non-small lung cancer cell lines, A549 and H1299, and non-cancerous MRC5. DK-164 demonstrated remarkable selectivity toward cancer cells and more pronounced cytotoxicity against A549. The cytotoxicity of CC-78 toward H1299 was even higher than that of the well-established anticancer drugs cisplatin and tamoxifen, but it did not reveal any noticeable selective effect. DK-164 showed predominantly pro-apoptotic activity in non-small cell lung carcinoma (NSCLC) cells, while CC-78 caused accidental cell death with features characteristic of necrosis. The level of induced autophagy was similar for both substances in cancer cells. DK-164 treatment of A549, H1299, and MRC5 cells for 48 h significantly increased the fluorescence signal of the NFkB (nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells) protein in the nucleus in all three cell lines, while CC-78 did not provoke NFkB translocation in any of the tested cell lines. Both compounds caused a significant transfer of the p53 protein in the nucleus of A549 cells but not in non-cancerous MRC5 cells. In A549, DK-164 generated oxidative stress close to the positive control after 48 h, while CC-78 had a moderate effect on the cellular redox status. In the non-cancerous cells, MRC5, both compounds produced ROS similar to the positive control for the same incubation period. The different results related to the cytotoxic potential of DK-164 and CC-78 associated with the examined cellular mechanisms induced in lung cancer cells might be used to conclude the specific functions of the various functional groups in the ferrocene compounds, which can offer new perspectives for the design of antitumour drugs.
Collapse
Affiliation(s)
- Maria Schröder
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
| | - Maria Petrova
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
| | - Zlatina Vlahova
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
| | - Georgi M. Dobrikov
- Institute of Organic Chemistry with Center of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 9, 1113 Sofia, Bulgaria; (G.M.D.); (I.S.)
| | - Ivaylo Slavchev
- Institute of Organic Chemistry with Center of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 9, 1113 Sofia, Bulgaria; (G.M.D.); (I.S.)
| | - Evdokia Pasheva
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
| | - Iva Ugrinova
- Institute of Molecular Biology “Akad. Roumen Tsanev”, Bulgarian Academy of Sciences, Acad. G. Bonchev Str, bl 21, 1113 Sofia, Bulgaria; (M.S.); (M.P.); (Z.V.); (E.P.)
- Correspondence: ; Tel.: +359-887-985-463
| |
Collapse
|
8
|
Czuczi T, Murányi J, Bárány P, Móra I, Borbély A, Csala M, Csámpai A. Synthesis and Antiproliferative Activity of Novel Imipridone–Ferrocene Hybrids with Triazole and Alkyne Linkers. Pharmaceuticals (Basel) 2022; 15:ph15040468. [PMID: 35455465 PMCID: PMC9028308 DOI: 10.3390/ph15040468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2022] [Revised: 04/06/2022] [Accepted: 04/09/2022] [Indexed: 12/10/2022] Open
Abstract
Imipridones, including ONC201, ONC206 and ONC212 (which are emblematic members of this class of compounds developed by Oncoceutics) constitute a novel class of anticancer agents, with promising results in clinical trials. With the aim of increasing the ROS (reactive oxygen species) responsivity of the synthesized molecules, a set of novel ferrocene–imipridone hybrids were designed and synthesized. Our strategy was motivated by the documented interplay between the imipridone-triggered activation of TRAIL (the tumor necrosis factor-related apoptosis-inducing ligand) and mitochondrial ClpP (Caseinolytic protease P) and the ROS-mediated effect of ferrocene-containing compounds. In order to obtain novel hybrids with multitarget characters, the ferrocene moiety was tethered to the imipridone scaffold through ethynylene and 1,2,3-triazolyl linkers by using Sonogashira coupling of Cu(I)- and Ru(II)-catalyzed azide–alkyne cycloadditions. The biological activities of the new hybrids were examined by using in vitro cell viability assays on four malignant cell lines (PANC-1, A2058, EBC-1 and Fadu), along with colony formation assays on the most resistant PANC-1 cell line. Several hybrids caused a significantly greater drop in the cell viability compared to ONC201, and two of them completely overcame the resistance, with IC50 values comparable to those produced by ONC201. The two most potent hybrids, but not ONC201, induced apoptosis/necrosis in PANC-1 and A2058 cells after 24 h of treatment.
Collapse
Affiliation(s)
- Tamás Czuczi
- Department of Organic Chemistry, Eötvös Loránd University (ELTE), Budapest Pázmány P. Sétány 1/A, H-1117 Budapest, Hungary; (T.C.); (P.B.)
| | - József Murányi
- MTA-SE Pathobiochemistry Research Group, Tűzoltó u. 37-47, H-1094 Budapest, Hungary; (J.M.); (I.M.); (M.C.)
| | - Péter Bárány
- Department of Organic Chemistry, Eötvös Loránd University (ELTE), Budapest Pázmány P. Sétány 1/A, H-1117 Budapest, Hungary; (T.C.); (P.B.)
| | - István Móra
- MTA-SE Pathobiochemistry Research Group, Tűzoltó u. 37-47, H-1094 Budapest, Hungary; (J.M.); (I.M.); (M.C.)
| | - Adina Borbély
- MTA-ELTE Lendület Ion Mobility Mass Spectrometry Research Group, Department of Analytical Chemistry, Eötvös Loránd University (ELTE), Budapest Pázmány P. Sétány 1/A, H-1117 Budapest, Hungary;
| | - Miklós Csala
- MTA-SE Pathobiochemistry Research Group, Tűzoltó u. 37-47, H-1094 Budapest, Hungary; (J.M.); (I.M.); (M.C.)
- Department of Molecular Biology, Semmelweis University, Tűzoltó u. 37-47, H-1094 Budapest, Hungary
| | - Antal Csámpai
- Department of Organic Chemistry, Eötvös Loránd University (ELTE), Budapest Pázmány P. Sétány 1/A, H-1117 Budapest, Hungary; (T.C.); (P.B.)
- Correspondence: ; Tel.: +36-1-372-2500 (ext. 6591)
| |
Collapse
|
9
|
Mathew B, Oh JM, Abdelgawad MA, Khames A, Ghoneim MM, Kumar S, Nath LR, Sudevan ST, Parambi DGT, Agoni C, Soliman MES, Kim H. Conjugated Dienones from Differently Substituted Cinnamaldehyde as Highly Potent Monoamine Oxidase-B Inhibitors: Synthesis, Biochemistry, and Computational Chemistry. ACS OMEGA 2022; 7:8184-8197. [PMID: 35284720 PMCID: PMC8908507 DOI: 10.1021/acsomega.2c00397] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Accepted: 02/11/2022] [Indexed: 02/08/2023]
Abstract
Fifteen multiconjugated dienones (MK1-MK15) were synthesized and evaluated to determine their inhibitory activities against monoamine oxidases (MAOs) A and B. All derivatives were found to be potent and highly selective MAO-B inhibitors. Compound MK6, with an IC50 value of 2.82 nM, most effectively inhibited MAO-B, like MK12 (IC50 = 3.22 nM), followed by MK5, MK13, and MK14 (IC50 = 4.02, 4.24, and 4.89 nM, respectively). The selectivity index values of MK6 and MK12 for MAO-B over MAO-A were 7361.5 and 1780.5, respectively. Compounds MK6 and MK12 were competitive reversible inhibitors of MAO-B, with K i values of 1.10 ± 0.20 and 3.0 ± 0.27 nM, respectively. Cytotoxic studies showed that MK5, MK6, MK12, and MK14 exhibited low toxicities on Vero cells, with IC50 values of 218.4, 149.1, 99.96, and 162.3 μg/mL, respectively, which were much higher than those for their effective nanomolar-level concentrations. Also, MK5, MK6, MK12, and MK14 decreased cell damage in H2O2-induced cells via a significant scavenging effect of reactive oxygen species. Molecular modeling was performed to rationalize the potential inhibitory activities of MK5, MK6, MK12, and MK14 toward MAO-B and their possible binding mechanisms, showing high-affinity binding pocket interactions and conformation perturbations of the compounds with MAO-B, which were interpreted as the conformational dynamics of MAO-B. This study concluded that all the compounds tested were more potent MAO-B inhibitors than the reference drugs, and leading compounds could be further explored for their effectiveness in various kinds of neurodegenerative disorders.
Collapse
Affiliation(s)
- Bijo Mathew
- Department
of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India
- ,
| | - Jong Min Oh
- Department
of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea
| | - Mohamed A. Abdelgawad
- Department
of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al Jouf 72341, Saudi Arabia
| | - Ahmed Khames
- Department
of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia
| | - Mohammed M. Ghoneim
- Department
of Pharmacy Practice, Faculty of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Saudi Arabia
| | - Sunil Kumar
- Department
of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India
| | - Lekshmi R. Nath
- Department
of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India
| | - Sachithra Thazhathuveedu Sudevan
- Department
of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India
| | - Della Grace Thomas Parambi
- Department
of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Al Jouf 72341, Saudi Arabia
| | - Clement Agoni
- Molecular
Bio-Computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4001, South
Africa
| | - Mahmoud E. S. Soliman
- Molecular
Bio-Computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4001, South
Africa
| | - Hoon Kim
- Department
of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea
| |
Collapse
|
10
|
Mbese Z, Nell M, Fonkui YT, Ndinteh DT, Steenkamp V, Aderibigbe BA. Hybrid Compounds Containing Carvacrol Scaffold: In Vitro Antibacterial and Cytotoxicity Evaluation. RECENT ADVANCES IN ANTI-INFECTIVE DRUG DISCOVERY 2022; 17:54-68. [PMID: 35078393 DOI: 10.2174/1574891x16666220124122445] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/29/2021] [Revised: 11/10/2021] [Accepted: 12/03/2021] [Indexed: 06/14/2023]
Abstract
BACKGROUND The design of hybrid compounds is a distinct approach for developing potent bioactive agents. Carvacrol, an essential oil, exhibits antimicrobial, antifungal, antioxidant, and anticancer activity, making it a good precursor for the development of compounds with potent biological activities. Some patents have reported carvacrol derivatives with promising biological activities. OBJECTIVE This study aimed to prepare hybrid compounds containing a carvacrol scaffold with significant antibacterial and anticancer activity. METHODS Esterification reactions between carvacrol and known pharmacophores were performed at room temperature and characterized using 1H-NMR, 13CNMR, and UHPLC-HRMS. In vitro antibacterial study was determined using the microdilution assay and cytotoxicity evaluation using sulforhodamine B staining assay. RESULTS The FTIR spectra of the carvacrol hybrids revealed prominent bands in the range of 1612-1764 cm-1 and 1014-1280 cm-1 due to (C=O) and (C-O) stretching vibrations, respectively. The structures of the carvacrol hybrids were confirmed by 1H-NMR, 13C-NMR, and UHPLC-HRMS analysis, and compound 5 exhibited superior activity when compared to the hybrid compounds against the strains of bacteria used in the study. The in vitro cytotoxicity evaluation showed that compound 3 induced cytotoxicity in all the cancer cell lines; MDA (16.57 ± 1.14 μM), MCF-7 (0.47 ± 1.14 μM), and DU145 (16.25 ± 1.08 μM), as well as the normal breast cells, MCF-12A (0.75± 1.30 μM). Compound 7 did not induce cytotoxicity in the cell lines tested (IC50 > 200 μM). CONCLUSION The modification of carvacrol through hybridization is a promising approach to develop compounds with significant antibacterial and anticancer activity.
Collapse
Affiliation(s)
- Zintle Mbese
- Department of Chemistry, Faculty of Science and Agriculture, University of Fort Hare, Alice, South Africa
| | - Margo Nell
- Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, South Africa
| | - Youmbi T Fonkui
- Department of Biotechnology and Food Technology, University of Johannesburg, Doornfontein Campus, Johannesburg, South Africa
| | - Derek T Ndinteh
- Department of Applied Chemistry, University of Johannesburg, Doornfontein Campus, Johannesburg, South Africa
| | - Vanessa Steenkamp
- Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, South Africa
| | - Blessing A Aderibigbe
- Department of Chemistry, Faculty of Science and Agriculture, University of Fort Hare, Alice, South Africa
| |
Collapse
|
11
|
Mathew B, Oh JM, Khames A, Abdelgawad MA, Rangarajan TM, Nath LR, Agoni C, Soliman MES, Mathew GE, Kim H. Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand Interactions. Pharmaceuticals (Basel) 2021; 14:ph14111148. [PMID: 34832930 PMCID: PMC8623647 DOI: 10.3390/ph14111148] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2021] [Revised: 11/01/2021] [Accepted: 11/09/2021] [Indexed: 02/05/2023] Open
Abstract
To develop new potent and highly selective MAO-B inhibitors from chalcone-thioethers, eleven chalcones-thioethers were synthesized and their monoamine oxidase (MAO) inhibition, kinetics, reversibility, and cytotoxicity of lead compounds were analyzed. Molecular dynamics were carried out to investigate the interactions. Compound TM8 showed potent inhibitory activity against MAO-B, with an IC50 value of 0.010 µM, followed by TM1, TM2, TM7, and TM10 (IC50 = 0.017, 0.021, 0.023, and 0.026 µM, respectively). Interestingly, TM8 had an extremely high selectivity index (SI; 4860) for MAO-B. Reversibility and kinetic experiments showed that TM8 and TM1 were reversible and competitive inhibitors of MAO-B with Ki values of 0.0031 ± 0.0013 and 0.011± 0.001 µM, respectively. Both TM1 and TM8 were non-toxic to Vero cells with IC50 values of 241.8 and 116.3 µg/mL (i.e., 947.7 and 402.4 µM), respectively, and at these IC50 values, both significantly reduced reactive oxygen species (ROS) levels. TM1 and TM8 showed high blood-brain barrier permeabilities in the parallel artificial membrane permeability assay. Molecular dynamics studies were conducted to investigate interactions between TM1 and TM8 and the active site of MAO-B. Conclusively, TM8 and TM1 are potent and highly selective MAO-B inhibitors with little toxicity and good ROS scavenging abilities and it is suggested that both are attractive prospective candidates for the treatment of neurological disorders.
Collapse
Affiliation(s)
- Bijo Mathew
- Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India
- Correspondence: or (B.M.); (H.K.)
| | - Jong Min Oh
- Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Korea;
| | - Ahmed Khames
- Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia;
| | - Mohamed A. Abdelgawad
- Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia;
| | - T. M. Rangarajan
- Department of Chemistry, Sri Venketeswara College, University of Delhi, New Delhi 110021, India;
| | - Lekshmi R. Nath
- Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi 682041, India;
| | - Clement Agoni
- Molecular Bio-Computation and Drug Design Laboratory, School of Health Sciences, Westville Campus, University of KwaZulu-Natal, Durban 4001, South Africa; (C.A.); (M.E.S.S.)
| | - Mahmoud E. S. Soliman
- Molecular Bio-Computation and Drug Design Laboratory, School of Health Sciences, Westville Campus, University of KwaZulu-Natal, Durban 4001, South Africa; (C.A.); (M.E.S.S.)
| | | | - Hoon Kim
- Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Korea;
- Correspondence: or (B.M.); (H.K.)
| |
Collapse
|
12
|
Kavitha N, Thamilarasan V, Sengottuvelan N. Diketonato based ferrocene appended cyclometalated iridium(III) complexes: Anti-microbial and anti-cancer studies. J Organomet Chem 2021. [DOI: 10.1016/j.jorganchem.2021.122032] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
13
|
Noori S, Nourbakhsh M, Farzaneh S, Zarghi A. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway. Anticancer Agents Med Chem 2021; 20:2285-2292. [PMID: 32767949 DOI: 10.2174/1871520620666200807103903] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2020] [Revised: 06/14/2020] [Accepted: 06/17/2020] [Indexed: 12/19/2022]
Abstract
BACKGROUND Breast cancer is the most common kind of cancer among women in the world. Despite major cancer therapy successes in recent years, cancer cells usually develop mechanisms to survive chemotherapy- induced cell death. Therefore, new strategies are needed to reverse cancer chemoresistance. OBJECTIVE The aim of this study was to investigate the effect of a recently-synthesized ferrocene derivative named 1-ferrocenyl-3-(4-methylsulfonylphenyl)propen-1-one (FMSP) on cisplatin resistance in MCF-7 cells, focusing on its inhibitory effects on Multi-Drug Resistance-1 (MDR-1) and inflammatory-related STAT3 pathway. METHODS Cisplatin-resistant MCF-7 cells were developed and the effect of cisplatin and FMSP on cell viability was examined by MTT assay. RT-PCR and Western blotting analyses were performed to assess the gene and protein expression of MDR-1 as well as phosphorylation of JAK2 and STAT3. RESULTS Overexpression of MDR1 as well as a marked increase in the level of phosphorylated STAT3 was observed in cisplatin-resistant MCF-7 (MCF-7R) cells. FMSP successfully reduced the MCF-7R cell viability and reversed both MDR1 expression and STAT3 phosphorylation status through which sensitivity of MCF-7R cells to cisplatin treatment was regained. CONCLUSION Our results indicated that FMSP may be considered as a promising therapeutic agent for the prevention and management of chemoresistance in breast cancer cells.
Collapse
Affiliation(s)
- Shokoofe Noori
- Department of Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Mitra Nourbakhsh
- Department of Biochemistry, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran,Finetech in Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Shabnam Farzaneh
- Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Afshin Zarghi
- Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| |
Collapse
|
14
|
Chen H, Zhang M, Wang Z, Li L, Li Q, Wang H. The Effect of p53-R249S on the Suppression of Hepatocellular Carcinoma Cells Survival Induced by Podophyllum Derivatives. Anticancer Agents Med Chem 2021; 20:865-874. [PMID: 32067620 DOI: 10.2174/1871520620666200218110047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2019] [Revised: 01/01/2020] [Accepted: 01/31/2020] [Indexed: 12/24/2022]
Abstract
BACKGROUND Hepatocellular Carcinoma (HCC), the second leading cause of cancer-related mortality with over half a million new cases diagnosed annually in the world, accounts for nearly 70% of cancer deaths in parts of Asia and Africa. Podophyllum, one of the important members of the lignane class of natural products derived from plants in Podophyllum peltatum L., has been shown to suppress tumor growth in various cancers. However, the effects of Podophyllum compounds on HCC and the mechanisms for its tumor-suppressive function remain unknown. METHODS A molecular docking study was employed to the analysis of the interaction between compounds and their targeted proteins. Cell proliferation was measured by MTT assay. Western blot analysis was used to evaluate protein expression. qRT-PCR was performed to assess RNA expression. RESULTS Molecular docking analysis was consistent with the beneficial effect of fluorine atom substituent in the 3-position of 2-aminopyridine in our previous study. Also, P-3F and D-3F displayed the most potent cytotoxicities against PLC/PRF/5 with p53-R249S and weakest inhibition of L02 (normal liver cell) growth. However, these derivatives had no effect on the suppression of HepG2 (wild-type p53) and Hep3B (p53-null) proliferation significantly. Further study showed that both compounds increase γ-H2AX expression in PLC/PRF/5 cell, along with repression of the c-Myc activation, purportedly by induction of p53 level and transcriptional activation. CONCLUSION The results suggested that podophyllum derivatives containing fluorine atom in the 3-position of 2- aminopyridine could inhibit the growth of HCC harboring p53-R249S by restoring the activity of p53 with decreasing the level of c-Myc.
Collapse
Affiliation(s)
- Huan Chen
- School of Public Health, Nanchang University, Nanchang, China,Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, China
| | - Mingyang Zhang
- School of Public Health, Nanchang University, Nanchang, China,Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, China
| | - Ziping Wang
- School of Public Health, Nanchang University, Nanchang, China,Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, China
| | - Lingqi Li
- School of Public Health, Nanchang University, Nanchang, China,Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, China
| | - Qiqi Li
- School of Public Health, Nanchang University, Nanchang, China,Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, China
| | - Huai Wang
- School of Public Health, Nanchang University, Nanchang, China,Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, Nanchang, China
| |
Collapse
|
15
|
Du G, Zhang Z, Lu X, Cai W, Wu L, Zhao G. A novel palladium (II) complex with a ferrocene-based ligand: Synthesis, X-ray crystallography and in vitro anticancer activity study. INORG CHEM COMMUN 2021. [DOI: 10.1016/j.inoche.2021.108448] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
16
|
Grabovskiy SA, Muhammadiev RS, Valiullin LR, Raginov IS, Kabal'nova NN. Synthesis and In Vitro Anticancer Activity of 6-Ferrocenylpyrimidin-4(3H)-one Derivatives. Curr Org Synth 2020; 16:160-164. [PMID: 31965930 DOI: 10.2174/1570179415666181113143516] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2018] [Revised: 10/26/2018] [Accepted: 10/27/2018] [Indexed: 11/22/2022]
Abstract
AIM AND OBJECTIVE Some ferrocenyl derivatives are active in vitro and in vivo against cancer. Generally, ferrocenyl derivatives for cancer research have three key components: a ferrocene moiety, a conjugated linker that lowers the oxidation potential and some derivative (peptide, nucleobase and others) that can interact with biomolecules. Since the pyrimidine fragment can easily pass through the membrane into the cells and become involved in metabolism; it appears to be promising. Furthermore, this fragment is an electron-acceptor group, so a spacer can be excluded. Therefore, the synthesis of 6-ferrocenylpyrimidin-4(3H)-one derivatives and the study of their anticancer activity have scientific and practical interest. METHODS The syntheses of 6-ferrocenylpyrimidin-4(3H)-one derivatives were performed by the condensation of ethyl 3-ferrocenyl-3-oxopropionate with thiourea or acetamidine or guanidine. The cytotoxicity of four 6- ferrocenylpyrimidin-4(3H)-one derivatives was evaluated by using the MTT assay in vitro against Human breast adenocarcinoma MCF-7 and normal human skin fibroblast HSF cells. The tested derivatives induced a concentration-dependent cytotoxic response in cell lines. RESULTS A study of the cytotoxic activity of 6-ferrocenylpyrimidin-4(3H)-one derivatives by the MTT test has found that all compounds have a dose-dependent toxic effect on the lines of breast cancer cells (MCF-7) and normal human fibroblast cells (HSF). The most pronounced cytotoxic effect is exhibited by 2-methyl-6-ferrocenylpyrimidin- 4(3H)-one (MCF-7, IC50 17 ± 1 µM). CONCLUSION The experimental results confirm the importance of investigation and design of ferrocenylpyrimidin- 4(3H)-one derivatives as anticancer agents. Compounds where the pyrimidine derivatives are directly linked to the ferrocene unit rather than via a spacer group also may be of interest for antiproliferative drug design.
Collapse
Affiliation(s)
- Stanislav A Grabovskiy
- Ufa Institute of Chemistry of the UFRC RAS, pr. Orkyabrya 69, 450054, Ufa, Russian Federation
| | - Rinat S Muhammadiev
- Federal Center for Toxicological, Radiation and Biological Safety, 420011, Kazan, Tatarstan, Russian Federation
| | - Lenar R Valiullin
- Federal Center for Toxicological, Radiation and Biological Safety, 420011, Kazan, Tatarstan, Russian Federation
| | - Ivan S Raginov
- Federal Center for Toxicological, Radiation and Biological Safety, 420011, Kazan, Tatarstan, Russian Federation
| | - Natalie N Kabal'nova
- Ufa Institute of Chemistry of the UFRC RAS, pr. Orkyabrya 69, 450054, Ufa, Russian Federation
| |
Collapse
|
17
|
Hu J, Liu S. Modulating intracellular oxidative stress via engineered nanotherapeutics. J Control Release 2020; 319:333-343. [DOI: 10.1016/j.jconrel.2019.12.040] [Citation(s) in RCA: 36] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2019] [Revised: 12/19/2019] [Accepted: 12/23/2019] [Indexed: 12/11/2022]
|
18
|
Wang R, Chen H, Yan W, Zheng M, Zhang T, Zhang Y. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships. Eur J Med Chem 2020; 190:112109. [PMID: 32032851 DOI: 10.1016/j.ejmech.2020.112109] [Citation(s) in RCA: 97] [Impact Index Per Article: 24.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2020] [Revised: 01/29/2020] [Accepted: 01/29/2020] [Indexed: 12/11/2022]
Abstract
Cancer is one of the most fatal threatens to human health throughout the world. The major challenges in the control and eradication of cancers are the continuous emergency of drug-resistant cancer and the low specificity of anticancer agents, creating an urgent need to develop novel anticancer agents. Organometallic compounds especially ferrocene derivatives possess remarkable structural and mechanistic diversity, inherent stability towards air, heat and light, low toxicity, low cost, reversible redox, ligand exchange, and catalytic properties, making them promising drug candidates for cancer therapy. Ferrocifen, a ferrocene-phenol hybrid, has demonstrated promising anticancer properties on drug-resistant cancers. Currently, Ferrocifen is in pre-clinical trial against cancers. Obviously, ferrocene moiety is a useful template for the development of novel anticancer agents. This review will provide an overview of ferrocene-containing hybrids with potential application in the treatment of cancers covering articles published between 2010 and 2020. The mechanisms of action, the critical aspects of design and structure-activity relationships are also discussed.
Collapse
Affiliation(s)
- Ruo Wang
- College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350116, China.
| | - Huahong Chen
- College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350116, China
| | - Weitao Yan
- College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350116, China
| | - Mingwen Zheng
- College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350116, China
| | - Tesen Zhang
- College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350116, China
| | - Yaohuan Zhang
- College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350116, China
| |
Collapse
|
19
|
Skoupilova H, Bartosik M, Sommerova L, Pinkas J, Vaculovic T, Kanicky V, Karban J, Hrstka R. Ferrocenes as new anticancer drug candidates: Determination of the mechanism of action. Eur J Pharmacol 2020; 867:172825. [DOI: 10.1016/j.ejphar.2019.172825] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2019] [Revised: 11/15/2019] [Accepted: 11/22/2019] [Indexed: 12/18/2022]
|
20
|
Peter S, Aderibigbe BA. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity. Molecules 2019; 24:molecules24193604. [PMID: 31591298 PMCID: PMC6804011 DOI: 10.3390/molecules24193604] [Citation(s) in RCA: 81] [Impact Index Per Article: 16.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2019] [Revised: 08/20/2019] [Accepted: 08/21/2019] [Indexed: 12/19/2022] Open
Abstract
Malaria and cancer are chronic diseases. The challenge with drugs available for the treatment of these diseases is drug toxicity and resistance. Ferrocene is a potent organometallic which have been hybridized with other compounds resulting in compounds with enhanced biological activity such as antimalarial and anticancer. Drugs such as ferroquine were developed from ferrocene and chloroquine. It was tested in the 1990s as an antimalarial and is still an effective antimalarial. Many researchers have reported ferrocene compounds as potent compounds useful as anticancer and antimalarial agents when hybridized with other pharmaceutical scaffolds. This review will be focused on compounds with ferrocene moieties that exhibit either an anticancer or antimalarial activity.
Collapse
Affiliation(s)
- Sijongesonke Peter
- Department of Chemistry, University of Fort Hare, Alice campus, Eastern Cape 5700, South Africa.
| | - Blessing Atim Aderibigbe
- Department of Chemistry, University of Fort Hare, Alice campus, Eastern Cape 5700, South Africa.
| |
Collapse
|
21
|
The Regulation of Cbf1 by PAS Kinase Is a Pivotal Control Point for Lipogenesis vs. Respiration in Saccharomyces cerevisiae. G3-GENES GENOMES GENETICS 2019; 9:33-46. [PMID: 30381292 PMCID: PMC6325914 DOI: 10.1534/g3.118.200663] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
PAS kinase 1 (Psk1) is a key regulator of respiration in Saccharomyces cerevisiae. Herein the molecular mechanisms of this regulation are explored through the characterization of its substrate, Centromere binding factor 1 (Cbf1). CBF1-deficient yeast displayed a significant decrease in cellular respiration, while PAS kinase-deficient yeast, or yeast harboring a Cbf1 phosphosite mutant (T211A) displayed a significant increase. Transmission electron micrographs showed an increased number of mitochondria in PAS kinase-deficient yeast consistent with the increase in respiration. Although the CBF1-deficient yeast did not appear to have an altered number of mitochondria, a mitochondrial proteomics study revealed significant differences in the mitochondrial composition of CBF1-deficient yeast including altered Atp3 levels, a subunit of the mitochondrial F1-ATP synthase complex. Both beta-galactosidase reporter assays and western blot analysis confirmed direct transcriptional control of ATP3 by Cbf1. In addition, we confirmed the regulation of yeast lipid genes LAC1 and LAG1 by Cbf1. The human homolog of Cbf1, Upstream transcription factor 1 (USF1), is also known to be involved in lipid biogenesis. Herein, we provide the first evidence for a role of USF1 in respiration since it appeared to complement Cbf1in vivo as determined by respiration phenotypes. In addition, we confirmed USF1 as a substrate of human PAS kinase (hPASK) in vitro. Combined, our data supports a model in which Cbf1/USF1 functions to partition glucose toward respiration and away from lipid biogenesis, while PAS kinase inhibits respiration in part through the inhibition of Cbf1/USF1.
Collapse
|
22
|
Singh A, Lumb I, Mehra V, Kumar V. Ferrocene-appended pharmacophores: an exciting approach for modulating the biological potential of organic scaffolds. Dalton Trans 2019; 48:2840-2860. [DOI: 10.1039/c8dt03440k] [Citation(s) in RCA: 78] [Impact Index Per Article: 15.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The present review article describes the recent developments (2014–18) on the synthesis of ferrocene-based pharmacophores with the specific benefits of introducing/replacing organic pharmacophores with the ferrocene core for desired bioactivities.
Collapse
Affiliation(s)
- Amandeep Singh
- Department of Chemistry
- Guru Nanak Dev University
- Amritsar-143005
- India
| | - Isha Lumb
- Department of Chemistry
- Baring Union Christian College
- Batala-143505
- India
| | - Vishu Mehra
- Department of Chemistry
- Hindu College
- Amritsar-143001
- India
| | - Vipan Kumar
- Department of Chemistry
- Guru Nanak Dev University
- Amritsar-143005
- India
| |
Collapse
|
23
|
Zhang Y, Wang C, Huang W, Haruehanroengra P, Peng C, Sheng J, Han B, He G. Application of organocatalysis in bioorganometallic chemistry: asymmetric synthesis of multifunctionalized spirocyclic pyrazolone–ferrocene hybrids as novel RalA inhibitors. Org Chem Front 2018. [DOI: 10.1039/c8qo00422f] [Citation(s) in RCA: 37] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Asymmetric construction of chiral spirocyclic pyrazolone–ferrocene hybrids has been developed. The lead compound displayed potent RalA inhibition.
Collapse
Affiliation(s)
- Yuehua Zhang
- State Key Laboratory of Biotherapy and Cancer Center
- West China Hospital
- Sichuan University
- Chengdu 610041
- China
| | - Chunting Wang
- State Key Laboratory of Biotherapy and Cancer Center
- West China Hospital
- Sichuan University
- Chengdu 610041
- China
| | - Wei Huang
- School of Pharmacy
- Chengdu University of Traditional Chinese Medicine
- Chengdu 611137
- China
| | - Phensinee Haruehanroengra
- Department of Chemistry and The RNA Institute
- University at Albany
- State University of New York
- Albany
- USA
| | - Cheng Peng
- School of Pharmacy
- Chengdu University of Traditional Chinese Medicine
- Chengdu 611137
- China
| | - Jia Sheng
- Department of Chemistry and The RNA Institute
- University at Albany
- State University of New York
- Albany
- USA
| | - Bo Han
- School of Pharmacy
- Chengdu University of Traditional Chinese Medicine
- Chengdu 611137
- China
- Department of Chemistry and The RNA Institute
| | - Gu He
- State Key Laboratory of Biotherapy and Cancer Center
- West China Hospital
- Sichuan University
- Chengdu 610041
- China
| |
Collapse
|
24
|
|
25
|
Guilmin R, Alloin F, Molton F, Leprêtre JC. Chemical modification of N-methylphenothiazine to lead to interesting and potential organic material for lithium battery. Electrochim Acta 2017. [DOI: 10.1016/j.electacta.2017.02.143] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
26
|
Zhan XP, Lan L, Wang S, Zhao K, Xin YX, Qi Q, Wang YL, Mao ZM. Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives. Chem Biodivers 2017; 14. [DOI: 10.1002/cbdv.201600219] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2016] [Accepted: 09/28/2016] [Indexed: 01/12/2023]
Affiliation(s)
- Xiao-Ping Zhan
- School of Pharmacy; Shanghai Jiaotong University; 800 Dongchuan Road Shanghai 200240 P. R. China
| | - Lan Lan
- School of Pharmacy; Shanghai Jiaotong University; 800 Dongchuan Road Shanghai 200240 P. R. China
| | - Shuai Wang
- School of Pharmacy; Shanghai Jiaotong University; 800 Dongchuan Road Shanghai 200240 P. R. China
| | - Kai Zhao
- School of Pharmacy; Shanghai Jiaotong University; 800 Dongchuan Road Shanghai 200240 P. R. China
| | - Yu-Xuan Xin
- School of Pharmacy; Shanghai Jiaotong University; 800 Dongchuan Road Shanghai 200240 P. R. China
| | - Qi Qi
- School of Pharmacy; Shanghai Jiaotong University; 800 Dongchuan Road Shanghai 200240 P. R. China
| | - Yao-Lin Wang
- School of Pharmacy; Shanghai Jiaotong University; 800 Dongchuan Road Shanghai 200240 P. R. China
| | - Zhen-Min Mao
- School of Pharmacy; Shanghai Jiaotong University; 800 Dongchuan Road Shanghai 200240 P. R. China
| |
Collapse
|
27
|
Tabrizi L, Chiniforoshan H. The cytotoxicity and mechanism of action of new multinuclear Scaffold AuIII, PdIIpincer complexes containing a bis(diphenylphosphino) ferrocene/non-ferrocene ligand. Dalton Trans 2017; 46:14164-14173. [DOI: 10.1039/c7dt02887c] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
New multinuclear gold(iii), palladium(ii) pincer complexes containing bis(diphenylphosphino) ferrocene/non-ferrocene ligands were investigated for their cytotoxicity and mechanism of action.
Collapse
Affiliation(s)
- Leila Tabrizi
- School of Chemistry
- National University of Ireland
- Galway
- Galway
- Ireland
| | | |
Collapse
|
28
|
Shin HJ, Moon S, Kim JC. Structure and Properties of Macrocyclic Nickel(II) Coordination Polymer Bearing 1,1'-Ferrocenedicarboxylate Bridging Ligand. JOURNAL OF THE KOREAN CHEMICAL SOCIETY-DAEHAN HWAHAK HOE JEE 2016. [DOI: 10.5012/jkcs.2016.60.6.467] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
29
|
Muenzner JK, Biersack B, Albrecht A, Rehm T, Lacher U, Milius W, Casini A, Zhang JJ, Ott I, Brabec V, Stuchlikova O, Andronache IC, Kaps L, Schuppan D, Schobert R. Ferrocenyl-Coupled N-Heterocyclic Carbene Complexes of Gold(I): A Successful Approach to Multinuclear Anticancer Drugs. Chemistry 2016; 22:18953-18962. [PMID: 27761940 DOI: 10.1002/chem.201604246] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2016] [Indexed: 11/11/2022]
Affiliation(s)
- Julienne K. Muenzner
- Organic Chemistry Laboratory; University Bayreuth; Universitätsstrasse 30 95447 Bayreuth Germany
| | - Bernhard Biersack
- Organic Chemistry Laboratory; University Bayreuth; Universitätsstrasse 30 95447 Bayreuth Germany
| | - Alexander Albrecht
- Organic Chemistry Laboratory; University Bayreuth; Universitätsstrasse 30 95447 Bayreuth Germany
| | - Tobias Rehm
- Organic Chemistry Laboratory; University Bayreuth; Universitätsstrasse 30 95447 Bayreuth Germany
| | - Ulrike Lacher
- Organic Chemistry Laboratory; University Bayreuth; Universitätsstrasse 30 95447 Bayreuth Germany
| | - Wolfgang Milius
- Lehrstuhl für Anorganische Chemie I; Universität Bayreuth; Universitätsstrasse 30 95447 Bayreuth Germany
| | - Angela Casini
- Department of Pharmacokinetics, Toxicology, and Targeting; University of Groningen; Antonius Deusinglaan 1 9713 Groningen The Netherlands
- School of Chemistry; Cardiff University, Main Building; CF10 3AT Cardiff UK
| | - Jing-Jing Zhang
- Medicinal and Pharmaceutical Chemistry; Technische Universität Braunschweig; Beethovenstrasse 55 38106 Braunschweig Germany
| | - Ingo Ott
- Medicinal and Pharmaceutical Chemistry; Technische Universität Braunschweig; Beethovenstrasse 55 38106 Braunschweig Germany
| | - Viktor Brabec
- Institute of Biophysics; Academy of Sciences of the Czech Republic; Kralovopolska 135 61265 Brno Czech Republic
- Department of Biophysics; Faculty of Science; Palacky University; Listopadu 12 77146 Olomouc Czech Republic
| | - Olga Stuchlikova
- Institute of Biophysics; Academy of Sciences of the Czech Republic; Kralovopolska 135 61265 Brno Czech Republic
- Department of Biophysics; Faculty of Science; Palacky University; Listopadu 12 77146 Olomouc Czech Republic
| | - Ion C. Andronache
- Research Centre for Integrated Analysis and Territorial Management; University of Bucharest; 1 Nicolae Balcescu bvd., District 1 010055 Bucharest Romania
| | - Leonard Kaps
- Institute of Translational Immunology; University Medical Center of the Johannes Gutenberg University; Langenbeckstrasse 1 55131 Mainz Germany
| | - Detlef Schuppan
- Institute of Translational Immunology; University Medical Center of the Johannes Gutenberg University; Langenbeckstrasse 1 55131 Mainz Germany
- Division of Gastroenterology; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston USA
| | - Rainer Schobert
- Organic Chemistry Laboratory; University Bayreuth; Universitätsstrasse 30 95447 Bayreuth Germany
| |
Collapse
|
30
|
Pérez WI, Rheingold AL, Meléndez E. Crystal structure of bis-[4-(1H-pyrrol-1-yl)phen-yl] ferrocene-1,1'-di-carboxyl-ate: a potential chemotherapeutic drug. Acta Crystallogr E Crystallogr Commun 2015; 71:536-9. [PMID: 25995874 PMCID: PMC4420060 DOI: 10.1107/s2056989015007446] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2015] [Accepted: 04/15/2015] [Indexed: 11/10/2022]
Abstract
The title iron(II) complex, [Fe(C16H12NO2)2], crystallizes in the ortho-rhom-bic space group Pbca with the Fe(2+) cation positioned on an inversion center. The cyclo-penta-dienyl (Cp) rings adopt an anti conformation in contrast with other substituted ferrocenes in which the Cp rings appear in a nearly eclipsed conformation. The Cp and the aromatic rings are positioned out of the plane, with a twist angle of 70.20 (12)°, and the C(Cp)-C(CO) bond length is shorter than a typical C-C single bond, which suggests a partial double-bond character and delocalization with the Cp π system. The structure of the complex is compared to other functionalized ferrocenes synthesized in our laboratory.
Collapse
Affiliation(s)
- Wanda I. Pérez
- University of Puerto Rico, Department of Chemistry, PO Box 9019, Mayaguez, Puerto Rico 00681, USA
| | - Arnold L. Rheingold
- University of California-San Diego, Department of Chemistry, Urey Hall 5128, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA
| | - Enrique Meléndez
- University of Puerto Rico, Department of Chemistry, PO Box 9019, Mayaguez, Puerto Rico 00681, USA
| |
Collapse
|